These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 25986736)

  • 1. Successful acquisition of a neutralizing monoclonal antibody against a novel neutrophil-activating peptide, mitocryptide-1.
    Hattori T; Nakashima K; Marutani T; Kiso Y; Nishi Y; Mukai H
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):54-9. PubMed ID: 25986736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of monoclonal antibodies against mitocryptide-2: toward a new strategy to investigate the biological roles of cryptides.
    Hattori T; Yamada T; Morikawa H; Marutani T; Tsutsumi K; Nishino K; Shimizu T; Nishi Y; Kiso Y; Mukai H
    J Pept Sci; 2017 Jul; 23(7-8):610-617. PubMed ID: 28370673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitocryptide-2, a neutrophil-activating cryptide, is a specific endogenous agonist for formyl-peptide receptor-like 1.
    Seki T; Fukamizu A; Kiso Y; Mukai H
    Biochem Biophys Res Commun; 2011 Jan; 404(1):482-7. PubMed ID: 21144840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitocryptide-2: purification, identification, and characterization of a novel cryptide that activates neutrophils.
    Mukai H; Seki T; Nakano H; Hokari Y; Takao T; Kawanami M; Tsukagoshi H; Kimura H; Kiso Y; Shimonishi Y; Nishi Y; Munekata E
    J Immunol; 2009 Apr; 182(8):5072-80. PubMed ID: 19342687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.
    Marutani T; Nishino K; Miyaji T; Kamada K; Ohura K; Kiso Y; Mukai H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and identification of novel neutrophil-activating cryptides hidden in mitochondrial cytochrome C.
    Hokari Y; Seki T; Nakano H; Matsuo Y; Fukamizu A; Munekata E; Kiso Y; Mukai H
    Protein Pept Lett; 2012 Jun; 19(6):680-7. PubMed ID: 22519541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial protein-derived cryptides: Are endogenous N-formylated peptides including mitocryptide-2 components of mitochondrial damage-associated molecular patterns?
    Marutani T; Hattori T; Tsutsumi K; Koike Y; Harada A; Noguchi K; Kiso Y; Mukai H
    Biopolymers; 2016 Nov; 106(4):580-7. PubMed ID: 26600263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity.
    Khurana S; Kennedy M; King LR; Golding H
    J Virol; 2005 Jun; 79(11):6791-800. PubMed ID: 15890918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of mitocryptide-1, a neutrophil-activating cryptide from healthy porcine heart.
    Mukai H; Hokari Y; Seki T; Takao T; Kubota M; Matsuo Y; Tsukagoshi H; Kato M; Kimura H; Shimonishi Y; Kiso Y; Nishi Y; Wakamatsu K; Munekata E
    J Biol Chem; 2008 Nov; 283(45):30596-605. PubMed ID: 18768476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel linear epitope on EspA from enterohemorrhagic E. coli using a neutralizing and protective monoclonal antibody.
    Yu S; Gu J; Wang HG; Wang QX; Luo P; Wu C; Zhang WJ; Guo G; Tong WD; Zou QM; Mao XH
    Clin Immunol; 2011 Jan; 138(1):77-84. PubMed ID: 21075691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.
    Connelly RJ; Kahn M; Blake J; Haffar OK; Thomas EK
    Virology; 1994 Dec; 205(2):554-7. PubMed ID: 7526543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Residues Critical for FPR2 Activation by the Cryptic Peptide Mitocryptide-2 Originating from the Mitochondrial DNA-Encoded Cytochrome
    Lind S; Gabl M; Holdfeldt A; Mårtensson J; Sundqvist M; Nishino K; Dahlgren C; Mukai H; Forsman H
    J Immunol; 2019 May; 202(9):2710-2719. PubMed ID: 30902901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody CL5 recognizes the amino terminal domain of human phagocyte flavocytochrome b558 large subunit, gp91phox.
    Baniulis D; Burritt JB; Taylor RM; Dinauer MC; Heyworth PG; Parkos CA; Magnusson KE; Jesaitis AJ
    Eur J Haematol; 2005 Apr; 74(4):337-47. PubMed ID: 15777347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine mapping of a linear epitope on EDIII of Japanese encephalitis virus using a novel neutralizing monoclonal antibody.
    Deng WL; Guan CY; Liu K; Zhang XM; Feng XL; Zhou B; Su XD; Chen PY
    Virus Res; 2014 Jan; 179():133-9. PubMed ID: 24184444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of B cell epitopes of dengue virus 2 NS3 protein by monoclonal antibody.
    Tian Y; Chen W; Yang Y; Xu X; Zhang J; Wang J; Xiao L; Chen Z
    Appl Microbiol Biotechnol; 2013 Feb; 97(4):1553-60. PubMed ID: 23081772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
    J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus.
    Wang YS; Fan HJ; Li Y; Shi ZL; Pan Y; Lu CP
    Vaccine; 2007 May; 25(22):4447-55. PubMed ID: 17445956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic properties of an anti-DNA antibody-derived peptide, 88H.64-80: location of a dominant idiotope defined by T and B cells.
    Ward FJ; Khan N; Wolger LJ; Howe CA; Eivazova ER; Harper N; Muller S; Staines NA
    J Autoimmun; 1998 Oct; 11(5):439-47. PubMed ID: 9802927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1.
    Laisney IL; Benjamin H; Gefter M; Strosberg AD
    Eur J Immunol; 1996 Jul; 26(7):1634-40. PubMed ID: 8766572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel recognition site on laminin for the alpha 3 beta 1 integrin.
    Pattaramalai S; Skubitz KM; Skubitz AP
    Exp Cell Res; 1996 Feb; 222(2):281-90. PubMed ID: 8598215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.